Researchers identified survival-associated genes that were deregulated in doxorubicin-induced heart failure patients with breast cancer and showed that, in these patients, low levels of IFIT5 expression were associated with shorter DFS [105]. This evidence concerns the gene IFIT5 and breast cancer.